EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

DegronMD: Leveraging Evolutionary and Structural Features for Deciphering Protein-Targeted Degradation, Mutations, and Drug Response to Degrons

Haodong Xu, Ruifeng Hu iD, Zhongming Zhao iD

Molecular Biology and Evolution · 2023

DOI: 10.1093/molbev/msad253 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology and Evolution, 2023. Verfasst von Haodong Xu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China. Hauptthemen laut MEDLINE: Degrons, Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Innovation Program of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein-targeted degradation is an emerging and promising therapeutic approach. The specificity of degradation and the maintenance of cellular homeostasis are determined by the interactions between E3 ubiquitin ligase and degradation signals, known as degrons. The human genome encodes over 600 E3 ligases; however, only a small number of targeted degron instances have been identified so far. In this study, we introduced DegronMD, an open knowledgebase designed for the investigation of degrons, their associated dysfunctional events, and drug responses. We revealed that degrons are evolutionarily conserved and tend to occur near the sites of protein translational modifications, particularly in the regions of disordered structure and higher solvent accessibility. Through pattern recognition and machine learning techniques, we constructed the degrome landscape across the human proteome, yielding over 18,000 new degrons for targeted protein degradation. Furthermore, dysfunction of degrons disrupts the degradation process and leads to the abnormal accumulation of proteins; this process is associated with various types of human cancers. Based on the estimated phenotypic changes induced by somatic mutations, we systematically quantified and assessed the impact of mutations on degron function in pan-cancers; these results helped to build a global mutational map on human degrome, including 89,318 actionable mutations that may induce the dysfunction of degrons and disrupt protein degradation pathways. Multiomics integrative analysis unveiled over 400 drug resistance events associated with the mutations in functional degrons. DegronMD, accessible at https://bioinfo.uth.edu/degronmd, is a useful resource to explore the biological mechanisms, infer protein degradation, and assist with drug discovery and design on degrons.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DegronsNeoplasmsHumansProteolysisProteasome Endopeptidase ComplexUbiquitin-Protein LigasesProteomeMutation

Stichwörter der Autor:innen

databasedegrondrug responsesevolutionary analysismachine learningprotein-targeted degradationubiquitin–proteasome system

Substanzen

Proteasome Endopeptidase ComplexUbiquitin-Protein LigasesProteome

Autor:innen und Institutionen

  • Department of Orthopaedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
  • Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
  • Center for Advanced Parkinson Research, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Genomics and Bioinformatics Hub, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX 77030, USA.
  • Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.

ORCID-Profile: Ruifeng Hu, Zhongming Zhao

Förderung

  • Science and Technology Innovation Program of Hunan Province

Zitieren

APA

Xu, H., Hu, R., & Zhao, Z. (2023). DegronMD: Leveraging Evolutionary and Structural Features for Deciphering Protein-Targeted Degradation, Mutations, and Drug Response to Degrons. Molecular Biology and Evolution. https://doi.org/10.1093/molbev/msad253

Vancouver

Xu H, Hu R, Zhao Z. DegronMD: Leveraging Evolutionary and Structural Features for Deciphering Protein-Targeted Degradation, Mutations, and Drug Response to Degrons. Molecular Biology and Evolution. 2023. doi:10.1093/molbev/msad253

BibTeX
@article{Xu2023,
  author = {Xu, Haodong and Hu, Ruifeng and Zhao, Zhongming},
  title = {DegronMD: Leveraging Evolutionary and Structural Features for Deciphering Protein-Targeted Degradation, Mutations, and Drug Response to Degrons},
  journal = {Molecular Biology and Evolution},
  year = {2023},
  doi = {10.1093/molbev/msad253}
}
Kostenlos starten →